Overview Financials News + Filings Key Docs Ownership Insiders
|
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 8-K | 10-K | 8-K | 10-K | S-1/A |
Revenues [+] | 0.0 | 72.8 | 0.0 | 37.9 | 0.0 | 0.0 |
Royalties | | 72.8 | | 37.9 | | |
Revenue growth | | 91.9% | | | | |
Cost of goods sold | 0.0 | 105.6 | 0.0 | 60.4 | 0.0 | 0.0 |
Gross profit | 0.0 | -32.9 | 0.0 | -22.5 | 0.0 | 0.0 |
Gross margin | | -45.1% | | -59.3% | | |
Selling, general and administrative [+] | 105.6 | 32.9 | 60.4 | 22.5 | 4.4 | 0.0 |
General and administrative | | 32.9 | | 22.5 | 4.4 | 0.0 |
Research and development | | | | | 9.1 | |
Other operating expenses | -9.2 | 39.9 | 20.6 | 15.4 | | |
EBITDA [+] | -94.1 | | -80.3 | | -13.4 | |
EBITDA growth | 17.1% | 74.8% | 500.5% | | 46034.5% | |
EBITDA margin | | -145.1% | | -159.3% | | |
Depreciation and amortization | 2.4 | | 0.7 | | 0.1 | |
EBIT [+] | -96.5 | -105.6 | -81.1 | -60.4 | -13.5 | 0.0 |
EBIT growth | 19.0% | 74.8% | 500.6% | | 46451.7% | |
EBIT margin | | -145.1% | | -159.3% | | |
Interest income | | 4.6 | | 0.0 | | |
Interest income | | 4.6 | | 0.0 | | |
Other income (expense), net [+] | -4.6 | | 10.3 | -10.3 | -54.9 | 0.0 |
Gain (loss) on investments | | -1.0 | | | | |
Pre-tax income | -101.1 | -101.1 | -70.8 | -70.8 | -68.4 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Net income | -101.1 | -101.1 | -70.8 | -70.8 | -68.4 | 0.0 |
Net margin | | -138.8% | | -186.5% | | |
|
Basic EPS [+] | ($1.84) | ($1.84) | ($2.45) | ($2.45) | ($29.93) | |
Growth | -24.7% | -24.7% | -91.8% | | | |
Diluted EPS [+] | ($1.84) | ($1.84) | ($2.45) | ($2.45) | ($29.93) | |
Growth | -24.7% | -24.7% | -91.8% | | | |
|
Shares outstanding (basic) [+] | 54.9 | 54.9 | 28.9 | 28.9 | 2.3 | |
Growth | 89.7% | 89.7% | 1166.1% | | | |
Shares outstanding (diluted) [+] | 54.9 | 54.9 | 28.9 | 28.9 | 2.3 | |
Growth | 89.7% | 89.7% | 1166.1% | | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|